Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancer

Cervical cancer (CC) remains a major disease burden on the female population worldwide. Chemotherapy with cisplatin (cis-diamminedichloroplatinum (II); CDDP) and related drugs are the main treatment option for CC; however, their efficacy is limited by the development of drug resistance. Noncoding RN...

Full description

Bibliographic Details
Main Authors: Xin Wen, Shui Liu, Jiyao Sheng, Manhua Cui
Format: Article
Language:English
Published: PeerJ Inc. 2020-05-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/9234.pdf
_version_ 1797425696661831680
author Xin Wen
Shui Liu
Jiyao Sheng
Manhua Cui
author_facet Xin Wen
Shui Liu
Jiyao Sheng
Manhua Cui
author_sort Xin Wen
collection DOAJ
description Cervical cancer (CC) remains a major disease burden on the female population worldwide. Chemotherapy with cisplatin (cis-diamminedichloroplatinum (II); CDDP) and related drugs are the main treatment option for CC; however, their efficacy is limited by the development of drug resistance. Noncoding RNAs (ncRNAs) have been found to play critical roles in numerous physiological and pathological cellular processes, including drug resistance of cancer cells. In this review, we describe some of the ncRNAs, including miRNAs, lncRNAs and circRNAs, that are involved in the sensitivity/resistance of CC to CDDP-based chemotherapy and discuss their mechanisms of action. We also describe some ncRNAs that could be therapeutic targets to improve the sensitivity of CC to CDDP-based chemotherapy.
first_indexed 2024-03-09T08:19:54Z
format Article
id doaj.art-b0207b26325048888381e2e39c3daa79
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T08:19:54Z
publishDate 2020-05-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-b0207b26325048888381e2e39c3daa792023-12-02T21:52:40ZengPeerJ Inc.PeerJ2167-83592020-05-018e923410.7717/peerj.9234Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancerXin WenShui LiuJiyao ShengManhua CuiCervical cancer (CC) remains a major disease burden on the female population worldwide. Chemotherapy with cisplatin (cis-diamminedichloroplatinum (II); CDDP) and related drugs are the main treatment option for CC; however, their efficacy is limited by the development of drug resistance. Noncoding RNAs (ncRNAs) have been found to play critical roles in numerous physiological and pathological cellular processes, including drug resistance of cancer cells. In this review, we describe some of the ncRNAs, including miRNAs, lncRNAs and circRNAs, that are involved in the sensitivity/resistance of CC to CDDP-based chemotherapy and discuss their mechanisms of action. We also describe some ncRNAs that could be therapeutic targets to improve the sensitivity of CC to CDDP-based chemotherapy.https://peerj.com/articles/9234.pdfCervical cancerCisplatin resistanceMicroRNALong non-coding RNACircular RNANoncoding RNAs
spellingShingle Xin Wen
Shui Liu
Jiyao Sheng
Manhua Cui
Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancer
PeerJ
Cervical cancer
Cisplatin resistance
MicroRNA
Long non-coding RNA
Circular RNA
Noncoding RNAs
title Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancer
title_full Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancer
title_fullStr Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancer
title_full_unstemmed Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancer
title_short Recent advances in the contribution of noncoding RNAs to cisplatin resistance in cervical cancer
title_sort recent advances in the contribution of noncoding rnas to cisplatin resistance in cervical cancer
topic Cervical cancer
Cisplatin resistance
MicroRNA
Long non-coding RNA
Circular RNA
Noncoding RNAs
url https://peerj.com/articles/9234.pdf
work_keys_str_mv AT xinwen recentadvancesinthecontributionofnoncodingrnastocisplatinresistanceincervicalcancer
AT shuiliu recentadvancesinthecontributionofnoncodingrnastocisplatinresistanceincervicalcancer
AT jiyaosheng recentadvancesinthecontributionofnoncodingrnastocisplatinresistanceincervicalcancer
AT manhuacui recentadvancesinthecontributionofnoncodingrnastocisplatinresistanceincervicalcancer